Abstract
Ovarian cancer is associated with high mortality due to asymptomatic nature of the disease and advance stage at presentation. In advanced stages, it is associated with cachexia and ascites leading to malnutrition. Nutritional status of a patient with cancer has been well known to be associated with survival and can be assessed by level of albumin in blood. Therefore, in this study, we sought to determine preoperative serum albumin as prognostic predictor of survival in patients with ovarian cancer. Preoperative serum albumin was determined in 235 patients undergoing surgery for ovarian cancer at Royal Derby Hospital. The prognostic predictive value of serum albumin, along with other prognostic markers was then analysed using univariate and multivariate analyses. Low serum albumin was associated with poor survival (P < 0.001) in patients with ovarian cancer. There was an inverse correlation between serum albumin levels and survival with lower levels having poor survival. Patients with serum albumin levels of <25 g/l had a median survival of 4.8 months (95% CI 0–13.1 months), whilst levels >35 g/l were associated with median survival of 43.2 months (95% CI 11.6–20.9). Serum albumin (P < 0.001) retained its significance as an independent predictor of poor survival on Cox’s multivariate regression analysis along with Age (P < 0.001) and FIGO stage (P < 0.001). Serum albumin can be used as an independent prognostic predictor of survival in patients with ovarian cancer.
Similar content being viewed by others
References
Ferlay JSH, Bray F, Forman D, Mathers C, Parkin DM. GLOBCAN. Available from: http://globocan.iarc.fr/factsheets/populations/factsheet.asp?uno=900#WOMEN (2008).
SEER. Available from: www.cancer.gov/cancertopics/types/ovarian (2010).
Cancer Research UK Ovarian Cancer incidence statistics. Cancer Research, UK. Available from: http://info.cancerresearchuk.org/cancerstats/types/ovary/incidence/index.htm (2007).
Laky B, et al. Malnutrition among gynaecological cancer patients. Eur J Clin Nutr. 2007;61(5):642–6.
Terada KY, Christen C, Roberts JA. Parenteral nutrition in gynaecology. J Reprod Med. 1988;33(12):957–60.
Garth AK, et al. Nutritional status, nutrition practices and post-operative complications in patients with gastrointestinal cancer. J Hum Nutr Diet. 2010;23(4):393–401.
Ottery FD.Supportive nutrition to prevent cachexia and improve quality of life. Semin Oncol. 1995;22(2 Suppl 3):98–111.
Burtis CA. A.E.T., textbook of clinical chemistry. Philadelphia: WB Saunders Company; 1999.
Andersson CE. Pretranslational regulation of albumin synthesis in tumor-bearing mice. The role of anorexia and undernutrition. Gastroenterology. 1991;100(4):938–45.
Heys SD, et al. Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coll Surg Edinb. 1998;43(3):163–8.
Schwartzbaum JA, et al. Presurgical serum albumin levels predict survival time from glioblastoma multiforme. J Neurooncol. 1999;43(1):35–41.
Lien YC, et al. Preoperative serum albumin level is a prognostic indicator for adenocarcinoma of the gastric cardia. J Gastrointest Surg. 2004;8(8):1041–8.
Al Murri AM, et al. Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Cancer. 2006;94(2):227–30.
Gadducci A et al. Malnutrition and cachexia in ovarian cancer patients: pathophysiology and management. Anticancer Res. 2001;21(4B):2941–2947.
Garcia-Luna PP, Parejo Campos J, Pereira Cunill JL. Causes and impact of hyponutrition and cachexia in the oncologic patient. Nutr Hosp. 2006;21 (Suppl 3):10–16.
Laky B, et al. Comparison of different nutritional assessments and body-composition measurements in detecting malnutrition among gynaecologic cancer patients. Am J Clin Nutr. 2008;87(6):1678–85.
Buzby GP, et al. Prognostic nutritional index in gastrointestinal surgery. Am J Surg. 1980;139(1):160–7.
Ingenbleek Y, Carpentier YA. A prognostic inflammatory and nutritional index scoring critically ill patients. Int J Vitam Nutr Res. 1985;55(1):91–101.
Bauer J, Capra S, Ferguson M. Use of the scored patient-generated subjective global assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr. 2002;56(8):779–85.
Parker D, et al. Serum albumin and CA125 are powerful predictors of survival in epithelial ovarian cancer. Br J Obstet Gynaecol. 1994;101(10):888–93.
Holschneider CH, Berek JS. Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol. 2000;19(1):3–10.
Fuhrman MP, Charney P, Mueller CM. Hepatic proteins and nutrition assessment. J Am Diet Assoc. 2004;104(8):1258–64.
Spiekerman AM. Nutritional assessment (protein nutriture). Anal Chem. 1995;67(12):429R–36R.
Campos AC, Meguid MM. A critical appraisal of the usefulness of perioperative nutritional support. Am J Clin Nutr. 1992;55(1):117–30.
Goonetilleke KS, Siriwardena AK. Systematic review of peri-operative nutritional supplementation in patients undergoing pancreaticoduodenectomy. JOP. 2006;7(1):5–13.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Asher, V., Lee, J. & Bali, A. Preoperative serum albumin is an independent prognostic predictor of survival in ovarian cancer. Med Oncol 29, 2005–2009 (2012). https://doi.org/10.1007/s12032-011-0019-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-011-0019-5